Skip to main content
Log in

Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants

  • Letter to the Editor
  • Published:
Journal of Perinatology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. McAdams RM, McPherson RJ, Mayock DE, Juul SE . Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol; 2013; 33: 226–230.

    Article  CAS  Google Scholar 

  2. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE . A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008; 122: 383–391.

    Article  Google Scholar 

  3. Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E et al. Neurodevelopmental outcome and growth at 18 to 22 months’ corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004; 114: 1287–1291.

    Article  Google Scholar 

  4. Bierer R, Peceny MC, Hartenberger CH, Ohls RK . Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006; 118: e635–e640.

    Article  Google Scholar 

  5. Brown MS, Eichorst D, Lala-Black B, Gonzalez R . Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 2009; 124: e681–e687.

    Article  Google Scholar 

  6. Neubauer AP, Voss W, Wachtendorf M, Jungmann T . Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010; 67: 657–666.

    CAS  PubMed  Google Scholar 

  7. Fauchère JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008; 122: 375–382.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Dame.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dame, C. Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants. J Perinatol 33, 411 (2013). https://doi.org/10.1038/jp.2012.140

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2012.140

  • Springer Nature America, Inc.

This article is cited by

Navigation